CAXTON CORP Diversified Active

CIK: 0001388551 · Show all filings

Period: Q2 2023 (← Previous) (Next →)

Filing Date: Aug 14, 2023

Total Value ($000): $34,653 (100.0% shares, 0.0% debt)

Holdings (7)

SVRA SAVARA INC 46.2%

Value ($000) $16,026 Shares 4,980,804 Est. Cost $1.66 Unrealized +41.2%

XERS XERIS BIOPHARMA HOLDINGS INC 42.7%

Value ($000) $14,782 Shares 5,641,920 Est. Cost $2.16 Unrealized +17.9%

RZLT REZOLUTE INC 7.5%

Value ($000) $2,612 Shares 1,318,967 Est. Cost $9.52 Unrealized -78.4%

— MOLECULAR TEMPLATES INC 2.8%

Value ($000) $985 Shares 2,052,991 Est. Cost $8.09 Unrealized —

CMPX COMPASS THERAPEUTICS INC 0.4%

Value ($000) $138 Shares 43,466 Est. Cost $3.99 Unrealized -21.3%

— ALLAKOS INC 0.2%

Value ($000) $77 Shares 17,733 Est. Cost $5.29 Unrealized —

— ELEVATION ONCOLOGY INC 0.1%

Value ($000) $33 Shares 21,725 Est. Cost $9.95 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
SVRA	SAVARA INC	4,980,804	$16,026	46.2%	$1.66	+41.2%	COM	805111101
XERS	XERIS BIOPHARMA HOLDINGS INC	5,641,920	$14,782	42.7%	$2.16	+17.9%	COM	98422E103
RZLT	REZOLUTE INC	1,318,967	$2,612	7.5%	$9.52	-78.4%	COM NEW	76200L309
—	MOLECULAR TEMPLATES INC	2,052,991	$985	2.8%	$8.09	—	COM	608550109
CMPX	COMPASS THERAPEUTICS INC	43,466	$138	0.4%	$3.99	-21.3%	COM	20454B104
—	ALLAKOS INC	17,733	$77	0.2%	$5.29	—	COM	01671P100
—	ELEVATION ONCOLOGY INC	21,725	$33	0.1%	$9.95	—	COM	28623U101